Friday, 19. December 2025 Share: Earnings 30. October 2024 19:43 Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro. Source: CNBC Continue reading...
Earnings Why Eli Lilly shares should be higher — plus, our wishlist for Nike's earnings 18. December 2025
Earnings A new generation of weight-loss drugs is getting closer to patients. Here’s how they differ from Wegovy and Zepbound. 18. December 2025
Earnings The next year will be for stock picking — and the next two weeks should see gains, says Goldman Sachs 18. December 2025